Loading...
Efficacy and safety of azilsartan medoxomil/chlortalidone fixed‐dose combination in hypertensive patients uncontrolled on azilsartan medoxomil alone: A randomized trial
Patients with grade 2‐3 essential hypertension and postplacebo mean clinic systolic blood pressure (SBP) 160‐190 mm Hg and 24‐hour SBP 140‐175 mm Hg by ambulatory blood pressure monitoring (ABPM) received 40 mg azilsartan medoxomil (AZL‐M) monotherapy for 4 weeks. “Nonresponders” were then randomize...
Na minha lista:
| Udgivet i: | J Clin Hypertens (Greenwich) |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8030929/ https://ncbi.nlm.nih.gov/pubmed/30302936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13376 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|